Projects per year
Personal profile
Personal profile
Dr. Biana Godin earned her Ph.D. in Pharmaceutical Sciences from the Hebrew University of Jerusalem in 2006. During her Ph.D. studies, Dr. Godin focused on designing a non-invasive treatment for the hard-to-treat skin deep infections and on nasal delivery of proteins. She was recruited as a Postdoctoral trainee in the field of Cancer Nanotechnology to the University of Texas Health Sciences Center. Her postdoctoral research focused on injectable multistage nanovectors (MSVs) for cancer treatment and imaging. Her work provided insightful understanding of the interactions of MSVs with immune cells in vivo and in vitro, biocompatibility of MSV, effect of geometry and targeting moieties on MSV biodistribution, and evaluation of MSV systems as near-infra red and MRI imaging agents. In October 2010, Dr. Godin joined the Department of Nanomedicine at the Research Institute.
Research in Dr. Godin's lab, largely funded by federal and foundation grants, focuses on developing physiologically relevant in vitro and in vivo disease models and exploiting physical and biological mechanisms to improve currently available therapeutic options in oncology and obstetrics. Dr. Godin considers herself a translational scientist on the interception of biological and physical sciences, with the ultimate goal of bringing advanced and safe therapies and the techniques to personalize therapies into the clinic to benefit patients.
Dr. Godin has more than 200 scientific publications, received multiple federal and foundation-based grants and participated in multiple national and international grant review panels.
Dr. Godin and her group published numerous peer-reviewed articles, book chapters and reviews in top journals including Nature Nanotechnology, Advanced Functional Materials, Journal of Controlled Release and Cancer Research. She also received national and international awards and other recognitions for her work and is on the editorial board and review board for numerous journals.
Research interests
Dr. Godin's research focuses primarily on the following areas:
-Employing principles of nanomedicine in Ob/Gyn
-Targeting liver metastasis with advanced nanocarriers
-Novel strategies to target tumor microenvironment
-Advanced patient-derived ex vivo disease models for personalized therapies
The main objective of these studies is to provide innovative approaches to treatment and diagnosis of cancer and Ob/Gyn disorders.
Education/Academic qualification
Pharmaceutics, Postdoctoral Fellowship, The Hebrew University of Jerusalem
Pharmaceutical Sciences, PhD, The Hebrew University of Jerusalem
MSc Pharm, The Hebrew University of Jerusalem
Nanomedicine, Postdoctoral Fellowship, University of Texas Health Science Center at Houston
External positions
Associate Professor of Nanomedicine in Obstetrics and Gynecology, Weill Cornell Medicine
Apr 1 2023 → …
Adjunct Assistant Professor, Obstetrics and Gynecology, University of Texas Health Science Center at Houston
Sep 1 2017 → …
Adjunct Assistant Professor, University of Houston
Adjunct Assistant Professor, University of Texas Graduate School of Biomedical Sciences at Houston
Research Area Keywords
- Cancer
- Nanomedicine
- Precision Medicine
Free-text keywords
- Nanomedicine
- Cancer
- Ob/Gyn
- Nano-therapeutics targeting
- Physical sciences in oncology
- Obstetrics
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Development of a Novel Therapeutic to Treat DNA Damage Associated with Atypical Burns
Godin, B. (PI)
9/15/24 → 9/14/27
Project: Federal Funding Agencies
-
Nanotechnology-based targeting of breast cancer liver metastases
Godin, B. (PI), Chen, S.-H. (Key Personnel), Niravath, P. A. (Key Personnel), Rosato, R. R. (Key Personnel) & Xu, S. (Key Personnel)
3/1/21 → 2/28/25
Project: Federal Funding Agencies
-
CPRIT RNA Therapeutics Core
Cooke, J. P. (PI), Godin, B. (Key Personnel) & Kiss, D. L. (Key Personnel)
8/31/20 → 8/30/25
Project: State
-
Intranasal Delivery of Telomerase Reverse Transcriptase mRNA for Therapy of Traumatic Brain Injury
Godin, B. (PI)
9/26/22 → 8/31/24
Project: Federal Funding Agencies
-
Evaluation of immune responses to CD44-targeted nanovectors for designing a novel anti-tuberculosis host-directed therapy
Godin, B. (PI), Jagannath, C. (PI) & Leonard, F. (Key Personnel)
5/1/20 → 10/31/22
Project: Federal Funding Agencies
-
Characterization of the Breast Cancer Liver Metastasis Microenvironment via Machine Learning Analysis of the Primary Tumor Microenvironment
Goodin, D. A., Chau, E., Zheng, J., O'Connell, C., Tiwari, A., Xu, Y., Niravath, P., Chen, S. H., Godin, B. & Frieboes, H. B., Oct 1 2024, In: Cancer research communications. 4, 10, p. 2846-2857 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Controlled Delivery of Rosuvastatin or Rapamycin through Electrospun Bismuth Nanoparticle-Infused Perivascular Wraps Promotes Arteriovenous Fistula Maturation
Barcena, A. J. R., Perez, J. V. D., Bernardino, M. R., San Valentin, E. M. D., Damasco, J. A., Klusman, C., Martin, B., Court, K. A., Godin, B., Canlas, G., Fowlkes, N., Bouchard, R. R., Cheng, J., Huang, S. Y. & Melancon, M. P., Jul 3 2024, In: ACS Applied Materials and Interfaces. 16, 26, p. 33159-33168 10 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Correction for partial volume averaging in the quantification of radiopaque nanomaterial-embedded resorbable polymers
Melancon, A. D., Jacobsen, M., Damasco, J., Perez, J., Bernardino, M., Valentin, E. S., Court, K. A., Godin, B., Layman, R. & Melancon, M. P., Sep 2024, In: Biomedical Physics and Engineering Express. 10, 5, 055021.Research output: Contribution to journal › Article › peer-review
Open Access -
Established and Emerging Nucleic Acid Therapies for Familial Hypercholesterolemia
Damase, T. R., Sukhovershin, R., Godin, B., Nasir, K. & Cooke, J. P., Aug 27 2024, In: Circulation. 150, 9, p. 724-735 12 p.Research output: Contribution to journal › Review article › peer-review
-
Image-Guided Deployment and Monitoring of a Novel Tungsten Nanoparticle–Infused Radiopaque Absorbable Inferior Vena Cava Filter in a Swine Model
San Valentin, E. M., Damasco, J. A., Bernardino, M., Court, K. A., Godin, B., Canlas, G. M., Melancon, A., Chintalapani, G., Jacobsen, M. C., Norton, W., Layman, R. R., Fowlkes, N., Chen, S. R., Huang, S. Y. & Melancon, M. P., Jan 2024, In: Journal of Vascular and Interventional Radiology. 35, 1, p. 113-121.e3Research output: Contribution to journal › Article › peer-review
Open Access
Prizes
-
2016 March of Dimes Award for Best Prematurity Research: Targeted liposomes direct the delivery of indomethacin to the uterus enhancing its tocolytic efficacy to reduce uterine contractions and preterm birth rate
Godin, B. (Recipient), 2016
Prize: Prize (including medals and awards)
-
2023 Outstanding Faculty Mentor Award, EnMed program
Godin, B. (Recipient), 2023
Prize: Other distinction
-
'ATCC Excellence Photograph Award’ for scientific content and image quality
Godin, B. (Recipient), 2014
Prize: Prize (including medals and awards)
-
Best PhD thesis in the College of Engineering, Swansea University
Godin, B. (Recipient), 2015
Prize: Other distinction
-